Joint Pain Pain Management
Aesculus Hippocastanum Whole And Ruta Graveolens Whole
Forces Of Nature
Human Otc Drug
NDC 51393-7591Joint Pain Pain Management also known as Aesculus Hippocastanum Whole And Ruta Graveolens Whole is a human otc drug labeled by 'Forces Of Nature'. National Drug Code (NDC) number for Joint Pain Pain Management is 51393-7591. This drug is available in dosage form of Solution/ Drops. The names of the active, medicinal ingredients in Joint Pain Pain Management drug includes Aesculus Hippocastanum Whole - 30 [hp_C]/1000mL Ruta Graveolens Whole - 30 [hp_C]/1000mL . The currest status of Joint Pain Pain Management drug is Active.
Drug Information:
| Drug NDC: | 51393-7591 |
| The labeler code and product code segments of the National Drug Code number, separated by a hyphen. Asterisks are no longer used or included within the product code segment to indicate certain configurations of the NDC. |
| Proprietary Name: | Joint Pain Pain Management |
| Also known as the trade name. It is the name of the product chosen by the labeler. |
| Proprietary Name Base: | Joint Pain |
| The base of the Brand/Proprietary name excluding its suffix. |
| Proprietary Name Suffix: | Pain Management |
| A suffix to the proprietary name, a value here should be appended to the ProprietaryName field to obtain the complete name of the product. This suffix is often used to distinguish characteristics of a product such as extended release (“XR”) or sleep aid (“PM”). Although many companies follow certain naming conventions for suffices, there is no recognized standard. |
| Product Type: | Human Otc Drug |
| Indicates the type of product, such as Human Prescription Drug or Human OTC Drug. This data element corresponds to the “Document Type” of the SPL submission for the listing. |
| Non Proprietary Name: | Aesculus Hippocastanum Whole And Ruta Graveolens Whole |
| Also known as the generic name, this is usually the active ingredient(s) of the product. |
| Labeler Name: | Forces Of Nature |
| Name of Company corresponding to the labeler code segment of the ProductNDC. |
| Dosage Form: | Solution/ Drops |
| The translation of the DosageForm Code submitted by the firm. There is no standard, but values may include terms like `tablet` or `solution for injection`.The complete list of codes and translations can be found www.fda.gov/edrls under Structured Product Labeling Resources. |
| Status: | Active |
| FDA does not review and approve unfinished products. Therefore, all products in this file are considered unapproved. |
| Substance Name: | AESCULUS HIPPOCASTANUM WHOLE - 30 [hp_C]/1000mL
RUTA GRAVEOLENS WHOLE - 30 [hp_C]/1000mL
|
| This is the active ingredient list. Each ingredient name is the preferred term of the UNII code submitted. |
| Route Details: | TOPICAL
|
| The translation of the Route Code submitted by the firm, indicating route of administration. The complete list of codes and translations can be found at www.fda.gov/edrls under Structured Product Labeling Resources. |
Marketing Information:
An openfda section: An annotation with additional product identifiers, such as NUII and UPC, of the drug product, if available.
| Marketing Category: | UNAPPROVED HOMEOPATHIC |
| Product types are broken down into several potential Marketing Categories, such as New Drug Application (NDA), Abbreviated New Drug Application (ANDA), BLA, OTC Monograph, or Unapproved Drug. One and only one Marketing Category may be chosen for a product, not all marketing categories are available to all product types. Currently, only final marketed product categories are included. The complete list of codes and translations can be found at www.fda.gov/edrls under Structured Product Labeling Resources. |
| Marketing Start Date: | 15 Jan, 2017 |
| This is the date that the labeler indicates was the start of its marketing of the drug product. |
| Marketing End Date: | 09 May, 2026 |
| This is the date the product will no longer be available on the market. If a product is no longer being manufactured, in most cases, the FDA recommends firms use the expiration date of the last lot produced as the EndMarketingDate, to reflect the potential for drug product to remain available after manufacturing has ceased. Products that are the subject of ongoing manufacturing will not ordinarily have any EndMarketingDate. Products with a value in the EndMarketingDate will be removed from the NDC Directory when the EndMarketingDate is reached. |
| Listing Expiration Date: | 31 Dec, 2023 |
| This is the date when the listing record will expire if not updated or certified by the firm. |
OpenFDA Information:
An openfda section: An annotation with additional product identifiers, such as NUII and UPC, of the drug product, if available.
| Manufacturer Name: | Forces of Nature
|
| Name of manufacturer or company that makes this drug product, corresponding to the labeler code segment of the NDC. |
| Original Packager: | Yes
|
| Whether or not the drug has been repackaged for distribution. |
| UNII: | 2331W47PSX
181JI0338P
|
| Unique Ingredient Identifier, which is a non-proprietary, free, unique, unambiguous, non-semantic, alphanumeric identifier based on a substance’s molecular structure and/or descriptive information. |
Packaging Information:
| Package NDC | Description | Marketing Start Date | Marketing End Date | Sample Available |
|---|
| 51393-7591-1 | 11 mL in 1 BOTTLE, DISPENSING (51393-7591-1) | 15 Jan, 2017 | N/A | No |
| 51393-7591-2 | 33 mL in 1 BOTTLE, DISPENSING (51393-7591-2) | 15 Jan, 2017 | N/A | No |
| 51393-7591-4 | 4 mL in 1 BOTTLE, DISPENSING (51393-7591-4) | 15 Jan, 2017 | N/A | No |
| Package NDC number, known as the NDC, identifies the labeler, product, and trade package size. The first segment, the labeler code, is assigned by the FDA. Description tells the size and type of packaging in sentence form. Multilevel packages will have the descriptions concatenated together. |
Purpose:
Active ingredients aesculus hippocastanum usda certified organic 30c - relieves arthritis ruta graveolens 30c - for painful joints
Product Elements:
Joint pain pain management aesculus hippocastanum whole and ruta graveolens whole aesculus hippocastanum whole aesculus hippocastanum whole ruta graveolens whole ruta graveolens whole sesame oil lavandin oil picea mariana leaf oil chamomile flower oil ginger oil pine needle oil (pinus sylvestris) cupressus sempervirens leaf oil rosemary oil
Indications and Usage:
Indications for the temporary relief of minor aches and pains of muscles and joints associated with arthritis.
Warnings:
Warnings some individuals may be sensitive to essential oils. begin with a small drop to determine if the product causes any increased redness or irritation and discontinue use if it irritates your skin. for external use only. if accidental ingestion of more than several drops, and adverse reaction occurs, get medical help or contact a poison control center. do not apply to the eyes. if you are pregnant or breast-feeding, ask a health professional before use. not for use on children under the age of 2 without physician direction. keep all medicines out of the reach of children. stop use and consult a doctor if condition worsens, or consult a doctor if symptoms show no improvement after 7 days.
Dosage and Administration:
Directions shake well before use. apply to affected area by gently rolling into the skin up to 3 or 4 times daily. for children under 2 years of age, consult a doctor before use.
Package Label Principal Display Panel:
Principal display panel - 11 ml bottle label forces of nature ® joint pain pain management fda registered homeopathic pain relief medicine usda organic .37 oz/11 ml principal display panel - 11 ml bottle label